carbonic anhydrase IX (CAIX)
Showing 1 - 25 of 213
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and
Recruiting
- Solid Tumor, Adult
- +2 more
- 89Zr-TLX250
- 177Lu-TLX250 and Peposertib
-
North Ryde, New South Wales, Australia
- +4 more
May 22, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)
Completed
- Clear Cell Renal Cell Carcinoma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 6, 2023
Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)
Not yet recruiting
- Clear Cell Renal Cell Carcinoma Metastatic
- +4 more
- (no location specified)
Jan 13, 2023
Triple Negative Breast Cancer Trial in Saint-Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Triple Negative Breast Cancer
- 89Zr-TLX250 PET/CT
-
Saint-Herblain, FranceICO René Gauducheau
Oct 18, 2021
Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Bladder Cancer
- 89Zr-TLX250 PET/CT
-
Saint Herblain, FranceInstitut de cancerologie de l'Ouest
Nov 24, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- AdGMCAIX-transduced autologous dendritic cells
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 28, 2021
Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States
Recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- 177Lu-labeled-girentuximab
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Feb 16, 2022
Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)
Completed
- Carcinoma, Renal Cell
- Clear Cell Renal Cell Carcinoma
- 89Zr-girentuximab
-
Yokohama City, Kanagawa, JapanYokohama City University Hospital
Aug 18, 2021
Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)
Recruiting
- Small Cell Lung Cancer
- acetazolamide in combination with platinum and etoposide-based radiochemotherapy
-
Nice, FranceCentre Antoine Lacassagne
Jan 19, 2023
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing
Active, not recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Tucson, Arizona
- +162 more
Oct 27, 2022
Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
-
Murdoch, Western Australia, AustraliaFiona Stanley Hospital
Aug 22, 2021
Carcinoma, Renal Cell Trial in Nijmegen (drug, radiation, procedure)
Recruiting
- Carcinoma, Renal Cell
-
Nijmegen, NetherlandsRadboudumc
Sep 23, 2021
Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Recruiting
- Clear Cell Renal Cell Carcinoma
- No intervention was required for patients or control group in this study
-
Jinan, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Mar 7, 2022
High Altitude Effects Trial (Acetazolamide 250Mg Tab, Methazolamide Pill, Placebo)
Not yet recruiting
- High Altitude Effects
- Acetazolamide 250Mg Tab
- +2 more
- (no location specified)
Oct 7, 2022
Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial in San Antonio (dietary supplement, drug, other)
Withdrawn
- Glaucoma
- +2 more
- Lumega-Z
- +2 more
-
San Antonio, TexasOphtalmology Clinic of William E Sponsel
Sep 30, 2022
Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)
Recruiting
- Clear Cell Renal Cell Carcinoma
- 89Zr-girentuximab
-
Duarte, California
- +29 more
Aug 4, 2021
Immunotherapy Trial in Xuzhou (CAR-T cell immunotherapy)
Recruiting
- Immunotherapy
- CAR-T cell immunotherapy
-
Xuzhou, Jiangsu, ChinaAffiliated Hospital of Xuzhou Medical University
Jul 17, 2021
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1
Completed
- Periodontitis
- Periodontal Inflammation
- Peirodontal clinical measurements and gingival crevicular fluid sampling
-
İzmir, TurkeyDokuz Eylul University, Faculty of Dentistry, Department of Peri
Jan 10, 2023
Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Recruiting
- Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)
Completed
- Metastatic Renal Cell Carcinoma
- HD IL2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jun 20, 2022
Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)
Not yet recruiting
- Cervical Cancer
- +13 more
- (no location specified)
Sep 28, 2022
Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)
Recruiting
- Glycogen Storage Disease VI
- +4 more
- No intervention
-
Durham, North CarolinaDuke University
Jul 27, 2022